Carol Conrad

Cystic fibrosis specialist, Heart and lung transplant specialist, Interstitial lung disease specialist, Interventional pulmonologist, Lung transplant specialist

Bio:   I have worked at LPCH/Stanford for 20 years. There have been many changes to the division since then, and we have grown substantially. I am the medical director of pediatric lung and heart-lung transplantation. The program began in 2004, and by learning from Dr. Norm Shumway and Dr. Bruce Reitz, we are now a stand alone pediatric lung transplant center since 2009.
Through my various interests in lung inflammation and transplantation, my research interests have evolved to study of bronchiolitis obliterans/CLAD in lung transplant recipients, and participate in ongoing NIH- sponsored clinical trials in lung transplantation.

Professional Education

  • Residency: Children's Hospital of Los Angeles (1992) CAUnited States of America
  • Internship: Children's Hospital of Los Angeles (1990) CAUnited States of America
  • Board Certification: Pediatric Pulmonary, American Board of Pediatrics (1996)
  • Fellowship: Johns Hopkins University (1995) MD
  • Medical Education: UCLA Medical Center (1989) CA
  • Fellow, The Johns Hopkins University, Pediatric Pulmonary Medicine (1995)
  • BA, Univ. of California, Berkeley, Anatomy and Physiology (1983)
  • MD, Drew-UCLA School of Medicine, Medicine (1989)

Administrative Appointments

  • Director, Pediatric Lung and Heart-Lung Transplant Program (2004 - Present)
  • Director, Pediatric Pulmonary Function Lab (1999 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.